Steven Cohen’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-483,980
Closed -$22.8M – 4339
2026
Q2
$22.8M Buy
483,980
+308,490
+176% +$7.62M 0.03% 810
2026
Q1
$3.32M Sell
175,490
-4,951
-3% -$84K ﹤0.01% 1972
2025
Q4
$2.42M Sell
180,441
-43,859
-20% -$543K ﹤0.01% 2358
2025
Q3
$2.64M Buy
+224,300
New +$2.09M ﹤0.01% 1333

Other funds holding DFTX

Steven Cohen's DFTX Position: Q3 2026 in Review

Steven Cohen sold out of Definium Therapeutics (DFTX) in Q3 2026, closing a stake of 483,980 shares — an estimated $22.8M sold.

Steven Cohen first reported a position in DFTX in Q3 2025 and held it in 4 quarters. The position peaked at $22.8M in Q2 2026. 354 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

  • Steven Cohen reported no remaining Definium Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Steven Cohen sold 483,980 Definium Therapeutics shares in Q3 2026, an estimated $22.8M.
  • Steven Cohen first reported a position in Definium Therapeutics in Q3 2025 and held it in 4 quarters.
  • Steven Cohen's Definium Therapeutics position peaked at $22.8M in Q2 2026.
  • 354 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.